8 Results for "

human cell-based assays

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "human cell-based assays" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-111551
CAS No.: 1630808-89-7
Purity:  99.39%
Research Areas:  

Cancer

FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. In cell-based assay, FT113 blocks FASN activity in BT474 cells (IC50, 90 nM). FT113 shows anti-proliferative activity, and exhibits anti-cancer activity both in vitro and in vivo .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-117427
CAS No.: 1236767-85-3
Purity:  99.90%
Research Areas:  

Metabolic Disease

D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor, with IC50s of 72 and 22 nM for rat and human D5D in enzymic and cell-based assays, respectively, has no effect on D6D or D9D activity. D5D-IN-326 reduces insulin resistance and decreases body weight in diet-induced obese C57BL/6J mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-115510
CAS No.: 1292285-54-1
Purity:  99.84%
Synonyms: SPRi3
Target:  

Carbonyl Reductase

Research Areas:  

Inflammation/Immunology

SPR inhibitor 3 (SPRi3) is a potent sepiapterin reductase (SPR) inhibitor. SPR inhibitor 3 (SPRi3) displays high binding affinity to human SPR in a cell-free assay (IC50=74 nM) and efficiently reduces biopterin levels in a cell-based assay (IC50=5.2 μM). SPR inhibitor 3 (SPRi3) reduces neuropathic and inflammatory pain through a reduction of BH4 levels .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111538
CAS No.: 2324160-91-8
Purity:  99.78%
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays .
loading...
    loading...
Cat. No.: HY-110134
CAS No.: 883226-64-0
Research Areas:  

Metabolic Disease

S07662 is a human constitutive androstane receptor (hCAR) inhibitor with an IC50 of 0.7 μM. S07662 recruits the corepressor NCoR in cell-based assays and attenuate the expression of CYP2B6 mRNA in human primary hepatocytes induced by phenytoin (HY-B0448) and CITCO (HY-103244) .
loading...
    loading...
Cat. No.: HY-187125
CAS No.: 946400-19-7
Target:  

11β-HSD

Research Areas:  

Others

11β-HSD1-IN-27 is a human and mouse 11β-hydroxysteroid dehydrogenase type I inhibitor. 11β-HSD1-IN-27 inhibits catalytic activity of target enzymes in cell-based assays. 11β-HSD1-IN-27 exhibits moderate stability in mouse and human liver microsomes .
loading...
    loading...
Cat. No.: HY-111538R
CAS No.: 2324160-91-8
Research Areas:  

Cancer

MAGL-IN-1 (Standard) is the analytical standard of MAGL-IN-1 (HY-111538). This product is intended for research and analytical applications. MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays .
loading...
    loading...
Cat. No.: HY-111551R
CAS No.: 1630808-89-7
Research Areas:  

Cancer

FT113 (Standard) is the analytical standard of FT113 (HY-111551). This product is intended for research and analytical applications. FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. In cell-based assay, FT113 blocks FASN activity in BT474 cells (IC50, 90 nM). FT113 shows anti-proliferative activity, and exhibits anti-cancer activity both in vitro and in vivo .
loading...
    loading...